Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis (Q47726405)

5 February 2018

review article

1 reference

title

Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis (English)

1 reference

5 February 2018

1 reference

1 reference

Holvoet P

1 reference

5 February 2018

Collen D

series ordinal

1 reference

5 February 2018

publication date

1 April 1998

1 reference

5 February 2018

published in

Atherosclerosis

1 reference

5 February 2018

volume

137 Suppl

1 reference

5 February 2018

page(s)

S33-8

1 reference

5 February 2018

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

The pathogenesis of atherosclerosis--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Preparation and biodistribution of 99mtechnetium labelled oxidized LDL in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Vitamin E consumption and the risk of coronary heart disease in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Vitamin E consumption and the risk of coronary disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Lack of effect of high dose vitamin E on xanthoma regression in homozygous familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Postmenopausal oestrogens and arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Estrogen modulates the inducible expression of platelet-derived growth factor mRNA by monocyte/macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

17 beta-Estradiol and smooth muscle cell proliferation in aortic cells of male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

HDL, its enzymes and its potential to influence lipid peroxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

The protective role of high-density lipoprotein on oxidized-low-density-lipoprotein-induced U937/endothelial cell interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Role of endothelium in thrombosis and hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

Lipid-lowering treatment: effects on endothelial dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900305-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(97)00305-5

1 reference

5 February 2018

1 reference

5 February 2018